HT is highly prevalent in malignant MCA infarction, regardless of IVT administration, with the majority of cases asymptomatic. Consequently, these findings suggest that asymptomatic HT may represent a natural progression of large infarcts rather than a treatment complication. The results underscore the need for early diagnostic markers and improved management strategies for HT in malignant MCA infarction.
Sehweil et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: